Masahiro Seike Selected Research

Masahiro Seike Research Topics

Disease

46	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2022 - 06/2003
41	Lung Neoplasms (Lung Cancer) 04/2022 - 06/2003
31	Neoplasms (Cancer) 01/2022 - 06/2003
13	Adenocarcinoma 01/2020 - 06/2003
12	Adenocarcinoma of Lung 04/2022 - 03/2006
9	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 06/2003
9	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2021 - 07/2016
6	Neoplasm Metastasis (Metastasis) 01/2021 - 06/2003
5	Idiopathic Pulmonary Fibrosis 09/2021 - 04/2011
5	Carcinogenesis 01/2021 - 08/2003
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2016 - 09/2004
5	Xanthomatosis (Xanthoma) 03/2007 - 12/2002
4	Fever (Fevers) 11/2022 - 05/2018
4	Pneumonia (Pneumonitis) 12/2019 - 07/2017
3	COVID-19 11/2022 - 05/2022
3	Organizing Pneumonia 01/2022 - 01/2019
3	Disease Progression 01/2022 - 05/2018
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021 - 07/2016
3	Dyspnea (Shortness of Breath) 12/2019 - 07/2017
3	Idiopathic Interstitial Pneumonias 12/2019 - 01/2011
3	Malignant Mesothelioma 02/2019 - 06/2014
3	Dermatitis 02/2019 - 10/2006
2	Cough 07/2022 - 07/2017
2	Vomiting 04/2022 - 01/2016
2	Chronic Obstructive Pulmonary Disease (COPD) 10/2021 - 03/2016
2	Pleural Effusion (Pleural Effusions) 01/2021 - 02/2013
2	Mesothelioma 01/2021 - 01/2018
2	Fibrosis (Cirrhosis) 01/2021 - 07/2020
2	Malignant Pleural Effusion 01/2020 - 02/2013
2	Hemorrhage 12/2019 - 01/2018
2	Nausea 01/2019 - 01/2016
2	Carcinoma (Carcinomatosis) 11/2018 - 07/2009
2	Renal Cell Carcinoma (Grawitz Tumor) 07/2017 - 04/2015
2	Breast Neoplasms (Breast Cancer) 04/2015 - 06/2010
2	Allergic Contact Dermatitis 04/2015 - 09/2012
2	Contact Dermatitis (Eczema, Contact) 10/2006 - 08/2005
2	Adenoma (Adenomas) 09/2003 - 08/2003

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 03/2021 - 08/2003
14	Tyrosine Kinase InhibitorsIBA 02/2022 - 11/2007
12	Carboplatin (JM8)FDA LinkGeneric 04/2022 - 06/2006
12	ErbB Receptors (EGF Receptor)IBA 04/2022 - 11/2007
9	Pharmaceutical PreparationsIBA 02/2021 - 06/2006
8	osimertinibIBA 02/2022 - 01/2018
8	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 04/2004
8	MicroRNAs (MicroRNA)IBA 01/2021 - 03/2006
7	pembrolizumabIBA 04/2022 - 01/2018
7	Biomarkers (Surrogate Marker)IBA 03/2022 - 12/2006
7	Gefitinib (Iressa)FDA Link 01/2021 - 12/2006
6	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2022 - 07/2016
5	Anaplastic Lymphoma KinaseIBA 03/2021 - 05/2013
5	B7-H1 AntigenIBA 03/2020 - 01/2018
4	Pemetrexed (MTA)FDA Link 02/2022 - 06/2014
4	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
4	Bevacizumab (Avastin)FDA Link 01/2022 - 02/2013
4	Paclitaxel (Taxol)FDA LinkGeneric 12/2019 - 06/2006
4	NivolumabIBA 02/2019 - 07/2017
4	Histamine (Histamine Dihydrochloride)FDA Link 01/2017 - 08/2005
4	Histone Deacetylase InhibitorsIBA 06/2010 - 11/2007
4	LDL Lipoproteins (beta Lipoproteins)IBA 03/2007 - 12/2002
4	oxidized low density lipoproteinIBA 03/2007 - 12/2002
3	Oxygen (Dioxygen)IBA 08/2022 - 01/2021
3	Albumin-Bound Paclitaxel FDA Link 04/2022 - 02/2019
3	SolutionsIBA 12/2021 - 01/2018
3	AfatinibIBA 04/2021 - 10/2018
3	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 03/2021 - 05/2012
3	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021 - 09/2012
3	RNA (Ribonucleic Acid)IBA 01/2020 - 11/2003
3	Monoclonal AntibodiesIBA 01/2019 - 07/2017
3	LigandsIBA 01/2018 - 12/2006
3	Irinotecan (Camptosar)FDA LinkGeneric 03/2013 - 04/2004
3	Messenger RNA (mRNA)IBA 06/2010 - 11/2003
3	DNA (Deoxyribonucleic Acid)IBA 01/2010 - 11/2003
2	CytokinesIBA 08/2022 - 08/2007
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2022 - 11/2012
2	SteroidsIBA 01/2022 - 11/2018
2	AntibodiesIBA 04/2021 - 01/2020
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021 - 07/2020
2	alectinibIBA 01/2020 - 01/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 02/2013
2	Docetaxel (Taxotere)FDA Link 01/2020 - 06/2006
2	Dexamethasone (Maxidex)FDA LinkGeneric 05/2018 - 01/2016
2	amrubicinIBA 07/2016 - 03/2013
2	ProteomeIBA 03/2016 - 09/2003
2	Peptides (Polypeptides)IBA 03/2016 - 07/2004
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2013 - 06/2003
2	Etoposide (VP 16)FDA LinkGeneric 10/2012 - 04/2011
2	Biological ProductsIBA 02/2009 - 09/2004
2	theasinensin AIBA 07/2008 - 11/2007
2	LipidsIBA 03/2007 - 12/2006
2	low density lipoprotein inhibitorIBA 03/2007 - 12/2002
2	Complementary DNA (cDNA)IBA 06/2006 - 06/2003
2	diphenylcyclopropenoneIBA 09/2005 - 08/2005
1	VaccinesIBA 11/2022

Therapy/Procedure

28	Therapeutics 08/2022 - 06/2003
18	Drug Therapy (Chemotherapy) 04/2022 - 01/2011
3	Aftercare (After-Treatment) 06/2018 - 04/2015
2	Pleurodesis 01/2020 - 02/2013
2	Radiotherapy 01/2019 - 04/2011
2	Combination Drug Therapy (Combination Chemotherapy) 04/2016 - 10/2012
2	Lasers (Laser) 07/2005 - 09/2003